Treatment of125I‐labelled high‐density lipoprotein ([125I]HDL3) with monospecific polyclonal antibodies against apolipoproteins A‐I and A‐II resulted in a dose‐dependent inhibition of the [125I]HDL3 binding to isolated human small intestine epithelial cells by 25%, and 50%, respectively. Both antibodies also inhibited intracellular degradation of [125I]HDL3 by 80%. Treatment of enterocytes with polyclonal antibody against apolipoprotein A‐I binding protein, a putative HDL receptor, inhibited both binding and degradation of [125I]HDL3 by these cells by 50%. Antibodies to apolipoprotein A‐I, A‐II and apo A‐I‐binding protein also inhibited [125I]HDL3 binding to cholesterol‐loaded cells.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.